MCL1 and chronic myelogenous leukemia, BCR-ABL1 positive: MCL1 is a BCR-ABL1-dependent survival factor, constitutively expressed in primary CML cells, that has been implicated in CML pathogenesis, whereas downregulation of MCL1 by antisense oligonucleotides is associated with increased sensitivity of K562 cells to imatinib [40].